Jonathan Hopper - Mar 1, 2022 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Chief Medical Officer
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Stock symbol
VCEL
Transactions as of
Mar 1, 2022
Transactions value $
-$403,931
Form type
4
Date filed
3/3/2022, 03:06 PM
Previous filing
Feb 22, 2022
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise $110K +10K +21.78% $10.95 55.9K Mar 1, 2022 Direct F1
transaction VCEL Common Stock Sale -$414K -10K -17.88% $41.41 45.9K Mar 1, 2022 Direct F1, F2
transaction VCEL Common Stock Options Exercise $180K +10K +21.78% $18.00 55.9K Mar 1, 2022 Direct F1
transaction VCEL Common Stock Sale -$279K -6.74K -12.05% $41.46 49.2K Mar 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Stock Option (right to buy) Options Exercise $0 -10K -21.01% $0.00 37.6K Mar 1, 2022 Common Stock 10K $10.95 Direct F3
transaction VCEL Stock Option (right to buy) Options Exercise $0 -10K -20.51% $0.00 38.8K Mar 1, 2022 Common Stock 10K $18.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.
F3 These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
F4 These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.